Dapagliflozin impurity

Dapagliflozin impurity is an enantiomer of Dapagliflozin which is a sodium-glucose transporter 2 inhibitor[1].

Product Specifications

CAS Number

[960404-86-8]

UNSPSC

12352005

Hazard Statement

H302, H315, H319, H335

Target

SGLT

Type

Reference compound

Related Pathways

Membrane Transporter/Ion Channel

Field of Research

Others

Assay Protocol

https://www.medchemexpress.com/dapagliflozin-impurity.html

Purity

99.63

Solubility

DMSO : 25 mg/mL (ultrasonic)

Smiles

O[C@]1(C2=CC=C(Cl)C(CC3=CC=C(OCC)C=C3)=C2)[C@@H]([C@H]([C@@H]([C@@H](CO)O1)O)O)O

Molecular Formula

C21H25ClO7

Molecular Weight

424.87

Precautions

H302, H315, H319, H335

References & Citations

[1]Kasichayanula S, et al. Lack of pharmacokinetic interaction between dapagliflozin, a novel sodium-glucose transporter 2 inhibitor, and metformin, pioglitazone, glimepiride or sitagliptin in healthy subjects. Diabetes Obes Metab. 2011 Jan;13 (1) :47-54.